333 related articles for article (PubMed ID: 19074870)
1. Cancer stem cells are enriched in the side population cells in a mouse model of glioma.
Harris MA; Yang H; Low BE; Mukherjee J; Guha A; Bronson RT; Shultz LD; Israel MA; Yun K
Cancer Res; 2008 Dec; 68(24):10051-9. PubMed ID: 19074870
[TBL] [Abstract][Full Text] [Related]
2. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
3. S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.
Chow KH; Park HJ; George J; Yamamoto K; Gallup AD; Graber JH; Chen Y; Jiang W; Steindler DA; Neilson EG; Kim BYS; Yun K
Cancer Res; 2017 Oct; 77(19):5360-5373. PubMed ID: 28807938
[TBL] [Abstract][Full Text] [Related]
4. Mouse induced glioma-initiating cell models and therapeutic targets.
Kondo T
Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
[TBL] [Abstract][Full Text] [Related]
5. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.
Lathia JD; Gallagher J; Myers JT; Li M; Vasanji A; McLendon RE; Hjelmeland AB; Huang AY; Rich JN
PLoS One; 2011; 6(9):e24807. PubMed ID: 21961046
[TBL] [Abstract][Full Text] [Related]
6. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
7. Induction of protumoral CD11c(high) macrophages by glioma cancer stem cells through GM-CSF.
Kokubu Y; Tabu K; Muramatsu N; Wang W; Murota Y; Nobuhisa I; Jinushi M; Taga T
Genes Cells; 2016 Mar; 21(3):241-51. PubMed ID: 26805963
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].
Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
Brain Nerve; 2009 Jul; 61(7):765-72. PubMed ID: 19618853
[TBL] [Abstract][Full Text] [Related]
9. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
[TBL] [Abstract][Full Text] [Related]
10. NKX2.2 suppresses self-renewal of glioma-initiating cells.
Muraguchi T; Tanaka S; Yamada D; Tamase A; Nakada M; Nakamura H; Hoshii T; Ooshio T; Tadokoro Y; Naka K; Ino Y; Todo T; Kuratsu J; Saya H; Hamada J; Hirao A
Cancer Res; 2011 Feb; 71(3):1135-45. PubMed ID: 21169405
[TBL] [Abstract][Full Text] [Related]
11. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
[TBL] [Abstract][Full Text] [Related]
12. Isolation of tumour stem-like cells from benign tumours.
Xu Q; Yuan X; Tunici P; Liu G; Fan X; Xu M; Hu J; Hwang JY; Farkas DL; Black KL; Yu JS
Br J Cancer; 2009 Jul; 101(2):303-11. PubMed ID: 19568241
[TBL] [Abstract][Full Text] [Related]
13. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
14. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.
Shingu T; Ho AL; Yuan L; Zhou X; Dai C; Zheng S; Wang Q; Zhong Y; Chang Q; Horner JW; Liebelt BD; Yao Y; Hu B; Chen Y; Fuller GN; Verhaak RG; Heimberger AB; Hu J
Nat Genet; 2017 Jan; 49(1):75-86. PubMed ID: 27841882
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation.
Wang W; Tabu K; Hagiya Y; Sugiyama Y; Kokubu Y; Murota Y; Ogura SI; Taga T
Sci Rep; 2017 Feb; 7():42070. PubMed ID: 28169355
[TBL] [Abstract][Full Text] [Related]
16. Alternative lengthening of telomeres in human glioma stem cells.
Silvestre DC; Pineda JR; Hoffschir F; Studler JM; Mouthon MA; Pflumio F; Junier MP; Chneiweiss H; Boussin FD
Stem Cells; 2011 Mar; 29(3):440-51. PubMed ID: 21425407
[TBL] [Abstract][Full Text] [Related]
17. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte Elevated Gene-1 Regulates β-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal.
Hu B; Emdad L; Kegelman TP; Shen XN; Das SK; Sarkar D; Fisher PB
Mol Cancer Res; 2017 Feb; 15(2):225-233. PubMed ID: 27903708
[TBL] [Abstract][Full Text] [Related]
19. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
20. Neutrophils promote the malignant glioma phenotype through S100A4.
Liang J; Piao Y; Holmes L; Fuller GN; Henry V; Tiao N; de Groot JF
Clin Cancer Res; 2014 Jan; 20(1):187-98. PubMed ID: 24240114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
